125 related articles for article (PubMed ID: 10644051)
1. Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.
Li Y; Glauert HP; Spear BT
Biochem Pharmacol; 2000 Feb; 59(4):427-34. PubMed ID: 10644051
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Spear BT; Glauert HP
Toxicol Appl Pharmacol; 2004 Aug; 199(1):1-9. PubMed ID: 15289085
[TBL] [Abstract][Full Text] [Related]
3. Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Lee EY; Spear BT; Glauert HP
Food Chem Toxicol; 2008 Jun; 46(6):2062-73. PubMed ID: 18336980
[TBL] [Abstract][Full Text] [Related]
4. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
5. Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB.
Li Y; Tharappel JC; Cooper S; Glenn M; Glauert HP; Spear BT
DNA Cell Biol; 2000 Feb; 19(2):113-20. PubMed ID: 10701777
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes.
Hong JT; Glauert HP
Toxicology; 1998 Nov; 131(2-3):99-107. PubMed ID: 9928625
[TBL] [Abstract][Full Text] [Related]
7. Activation of the activator protein-1 by the peroxisome proliferator clofibric acid in rat H4IIEC3 hepatoma cells.
Bécuwe P; Bianchi A; Dauça M
Toxicol Appl Pharmacol; 2001 Aug; 174(3):294-301. PubMed ID: 11485390
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.
Nilakantan V; Spear BT; Glauert HP
Carcinogenesis; 1998 Apr; 19(4):631-7. PubMed ID: 9600348
[TBL] [Abstract][Full Text] [Related]
9. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
Hong JT; Yun YP
Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofibrate.
Tharappel JC; Nalca A; Owens AB; Ghabrial L; Konz EC; Glauert HP; Spear BT
Toxicol Sci; 2003 Oct; 75(2):300-8. PubMed ID: 12883078
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate.
Passilly P; Schohn H; Jannin B; Cherkaoui Malki M; Boscoboinik D; Dauça M; Latruffe N
Biochem Pharmacol; 1999 Sep; 58(6):1001-8. PubMed ID: 10509752
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate.
Tharappel JC; Cunningham ML; Spear BT; Glauert HP
Toxicol Sci; 2001 Jul; 62(1):20-7. PubMed ID: 11399789
[TBL] [Abstract][Full Text] [Related]
13. Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene.
Zhang B; Marcus SL; Miyata KS; Subramani S; Capone JP; Rachubinski RA
J Biol Chem; 1993 Jun; 268(17):12939-45. PubMed ID: 8389766
[TBL] [Abstract][Full Text] [Related]
14. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
[TBL] [Abstract][Full Text] [Related]
15. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase.
Zhang B; Marcus SL; Sajjadi FG; Alvares K; Reddy JK; Subramani S; Rachubinski RA; Capone JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7541-5. PubMed ID: 1502166
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
Duclos S; Bride J; Ramirez LC; Bournot P
Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate.
Glauert HP; Beaty MM; Clark TD; Greenwell WS; Tatum V; Chen LC; Borges T; Clark TL; Srinivasan SR; Chow CK
J Cancer Res Clin Oncol; 1990; 116(4):351-6. PubMed ID: 1975253
[TBL] [Abstract][Full Text] [Related]
18. Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity.
Nilakantan V; Spear BT; Glauert HP
Free Radic Biol Med; 1998 Jun; 24(9):1430-6. PubMed ID: 9641260
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
Rao MS; Lalwani ND; Watanabe TK; Reddy JK
Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
[TBL] [Abstract][Full Text] [Related]
20. Effects of the peroxisome proliferator clofibric acid on superoxide dismutase expression in the human HepG2 hepatoma cell line.
Bécuwe P; Bianchi A; Keller JM; Dauça M
Biochem Pharmacol; 1999 Sep; 58(6):1025-33. PubMed ID: 10509755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
